06.10.24 -- 4 Strategies To Formulate Poorly Soluble APIs

Increased demand for protein delivery and the emergence of advanced modalities – including mRNA – are introducing new challenges to the development lifecycle, such as high-concentration formulations.

Whether bringing a novel therapy to market or altering current devices, companies must determine the best selection for administration without impacting drug efficacy, quality, and safety.

Examine the benefits of controlled release, the application of PBPK modeling in formulation development, and how modified release products can be developed to deliver optimal patient outcomes.

Learn about new data on nanotechnology formulations for multiple dose forms and routes of delivery, including oral, long acting injectables, inhalation, and ophthalmic.

Automated manufacturing is a powerful but often misunderstood tool available to produce drug delivery and other pharmaceutical devices — whether established designs or innovative new ideas.

Review a commercially ready process that not only reduces manufacturing complexity and environmental impact but also holds the capability to out-design and outperform spray drying.

Explore the key findings of a new wearable injector clinical trial, including its positive impact on patient experience and the broader benefits of wearable injectors for chronic disease management.